AffyXell Therapeutics develops novel mesenchymal stem cell therapies.
Business Model:
Revenue: $0
Employees: 1-10
Address: Gimhae Biomedical Industry Promotion Institute Techno Town, 80-59, Golden Route
City: Juchon-myeon
State: gyeonggido
Zip: 1492
Country: KR
AffyXell was established in January 2020 by Avacta and Daewoong as a joint venture to develop novel mesenchymal stem cell (MSC) therapies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2022 | Corporate Round | 1 | - |
Avacta Group Avacta Group |
2/2021 | Series A | $0 |
Gyeongnam Venture Investment Kolon Investment Samsung Venture Investment Shinhan Investment Shinhan Venture Investment Smilegate Investment Stonebridge Ventures Gyeongnam Venture Investment Kolon Investment Samsung Venture Investment Shinhan Investment Shinhan Venture Investment Smilegate Investment Stonebridge Ventures |
4/2022 | Corporate Round | 1 | - |
Avacta Group Avacta Group |
2/2021 | Series A | 7 | $7.3M |
Gyeongnam Venture Investment Kolon Investment Samsung Venture Investment Shinhan Investment Shinhan Venture Investment Smilegate Investment Stonebridge Ventures Gyeongnam Venture Investment Kolon Investment Samsung Venture Investment Shinhan Investment Shinhan Venture Investment Smilegate Investment Stonebridge Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|